Xconomy’s Digital Events →
Scribe Therapetics co-founder and vice president of platform Brett Staahl (left) and co-founder and CEO Benjamin Oakes (right). Photo by Scribe Therapeutics.
Sponsored · Whitepaper
A Guide to Performing Check-ups on Pharmaceutical Distribution & Patient Access Programs
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.